carbonthatcarbonthat
← Every company

Kirin Holdings Co Ltd Patents

What Kirin Holdings Co Ltd has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.

KNBWY on carbonthat →
Filings on file
45
Granted
3
Still pending
42
Filed under
8 names

45 filings

Newest filing first. A pending application has no patent number yet, and most never get one.

InventionPatent
ANTI-FGF23 ANTIBODY OR ANTIBODY FRAGMENT THEREOFA61K 39/395, C07K 16/22, A61P 7/00, A61P 19/08, A61K2039/505, C07K 16/00, C07K2317/52, C07K2317/524, C07K2317/526, C07K2317/56, C07K2317/565, C07K2317/72, C07K2317/76, C07K2317/92, C07K2317/94, C12N 5/10, C12N 15/63, C12N 15/74, C12N 15/80, C12N 15/81Filed as Kyowa Kirin Co., Ltd.2026-03-26Hikaru MIYAGIpending
ANTI-FGF23 ANTIBODY OR ANTIBODY FRAGMENT THEREOFA61K 39/395, C07K 16/22, A61P 7/00, A61P 19/08, A61K2039/505, C07K 16/00, C07K2317/52, C07K2317/524, C07K2317/526, C07K2317/56, C07K2317/565, C07K2317/72, C07K2317/76, C07K2317/92, C07K2317/94, C12N 5/10, C12N 15/63, C12N 15/74, C12N 15/80, C12N 15/81Filed as Kyowa Kirin Co., Ltd.2026-01-29Hikaru MIYAGIpending
BEER-TASTE FERMENTED ALCOHOLIC BEVERAGE AND PRODUCTION METHOD THEREFORC12C 11/003, C12C 7/01, C12C 7/205, C12C 7/26, C12C 11/11, C12C2200/31Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-12-29Yuri TSUCHIYApending
BEER-FLAVORED ALCOHOLIC BEVERAGE AND METHOD FOR PRODUCING THE SAMEC12C 5/004, C12C 11/00, C12C 12/00Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-12-29Masaru KATOUpending
BEER-FLAVORED FERMENTED MALT ALCOHOLIC BEVERAGE AND METHOD FOR PRODUCING SAMEC12C 5/02, C12C 11/003, C12C 12/00Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-12-29Nobumichi MIYOSHIpending
METHOD FOR PRODUCING BEVERAGE WITH ENHANCED AROMA OF CITRUS FRUITC12G 3/055, C12G2200/21Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-12-16Tomonori KANOpending
METHOD FOR PRODUCING A MICROORGANISM HAVING N-DEACETYLATION ACTIVITY AND N-SULFATION ACTIVITY, METHOD FOR PRODUCING A HEPAROSAN-DERIVED COMPOUND, AND A MICROORGANISM HAVING N-DEACETYLATION ACTIVITY AND N-SULFATION ACTIVITYC12N 9/13, C12N 15/52, C12P 19/26, C12Y 208/02008, C12Y 208/02023, C12Y 208/02029Filed as KIRIN BIOMATERIALS CO., LTD.2025-11-26Marc DOUAISIpending
BEER-FLAVORED ALCOHOLIC BEVERAGE AND METHOD FOR PRODUCING THE SAMEC12C 12/00, C12C 5/02, C12C 7/00, C12C 11/003Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-10-27Akira HORIEpending
METHOD FOR DEPOLYMERIZING POLYESTERC07C 51/09, C08J 11/24, Y02W 30/62, C07C 29/095, C08G 63/88, C08J 11/16, C08J 11/22, C08J2367/02, C07C 63/26, C07C 31/202Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-10-24Yoshimasa TANIGUCHIpending
COMPOSITION FOR PREVENTING OR TREATING CHEMOSENSORY DISORDERA61P 27/00, A61K 35/744, A61P 43/00, A61P 31/14, A61K 35/747Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-09-30Kazuko YAMAMOTOpending
NON-ALCOHOLIC BEER-TASTE BEVERAGE HAVING SUPPRESSED SOY SAUCE-LIKE AROMAC12H 3/02, A23L 2/56, A23L 2/00, A23L 2/38, A23L 2/52, C12C 5/02, C12C 5/026, C12C 12/04Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-06-20Manami SUZUKIpending
PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATIONA61K 35/744, A61P 37/04, A61K 9/0043, A61K2035/115Filed as Kirin Holdings Kabushiki Kaisha2025-06-18Hiroshi ISHIIpending
NON-ALCOHOLIC BEER-TASTE BEVERAGE HAVING SUPPRESSED SOURNESSA23L 2/382, A23L 2/52, A23L 2/00, A23L 2/38, A23L 2/56, A23V2002/00, A23V2200/06, C12C 5/02, C12C 12/04Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-06-18Kazumasa SUNAHARApending
THE EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATIONC07K 16/22, A61P 19/08, A61K 39/001132, A61K2039/505, A61K2039/54, A61K2039/545, C07K2317/21, C07K2317/565, C07K2317/76, C07K2317/90Filed as Kyowa Kirin Co., Ltd.2025-06-11Emil D. KAKKISpending
PROTEIN HAVING POLYETHYLENE TEREPHTHALATE DECOMPOSING ACTIVITY AND METHOD FOR DECOMPOSING POLYETHYLENE TEREPHTHALATEC12N 9/18, Y02W 30/62, C08J 11/105, C08J 11/16, C08J2367/02, C12P 7/44, C12P 7/62, C12Y 301/01Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-06-09Takashi MATSUZAKIpending
LACTIC ACID BACTERIA-CONTAINING BEVERAGE WITH TASTE DISHARMONY IMPROVED AND METHOD FOR PRODUCING THE SAMEC12G 3/02, A23L 2/382, A23L 2/56, C12G 3/04, C12G 3/06Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-05-29Maki OKADApending
BEER-FLAVORED ALCOHOLIC BEVERAGE AND METHOD FOR PRODUCING THE SAMEC12G 3/04, A23L 2/56, C12C 5/02, C12C 5/026, C12G 3/06Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-05-29Akira HORIEpending
PACKAGED ACIDIC BEVERAGEA23L 2/382, A23L 2/68, A23V2400/175, A23C 9/12, A23L 2/66Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-05-28Mihoko SUZUKIpending
PACKAGED SUGAR-FREE BEVERAGEA23L 2/38, A23V2400/175, A23L 2/54, A23L 2/68Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-05-28Kiichi YOKOYAMApending
COMPOSITION FOR PROVIDING PLANT WITH STRESS RESISTANCEA01N 37/46, A01P 21/00Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-04-10Takeshi HIRAKAWApending
METHOD FOR PRODUCING QUINOXALINE DERIVATIVEA61P 35/00, C07D 401/14, B01J 31/2295, C07B 53/00, C07B2200/13, C07D 213/61Filed as Kyowa Kirin Co., Ltd.2025-02-27Kazunobu TAKEMURApending
BISPECIFIC ANTIBODY BINDING TO TfRC07K 16/2881, A61P 35/00, G01N 33/575, A61K2039/505, C07K 16/2863, C07K 16/303, C07K2317/31, C07K2317/34, C07K2317/515, C07K2317/55, C07K2317/56, C07K2317/565, C07K2317/64, C07K2317/73, C07K2317/76, C07K2317/92Filed as Kyowa Kirin Co., Ltd.2025-02-19Keisuke MITAMURApending
ANTIBODY OR FRAGMENT THEREOF THAT BINDS TO FCRL1C07K 16/283, A61K 47/68, A61K 47/6849, A61P 37/00, A61P 37/02, A61P 35/02, A61P 29/00, A61P 35/00, A61K 47/68035, G01N 33/5759, A61K2039/505, C07K2317/14, C07K2317/24, C07K2317/56, C07K2317/565, C07K2317/77, C07K2317/92, C12N 5/12, C12N2510/00, G01N 33/564, G01N 33/68, G01N 33/6872, G01N 33/6893, G01N2333/70535, G01N2800/7095Filed as Kyowa Kirin Co., Ltd.2025-02-14Satoshi NAGATApending
COMPOSITION FOR PREVENTING OR IMPROVING HEPATIC DYSFUNCTIONA23L 33/175, A61K 31/198, A61P 1/16, A61P 31/20, A61P 31/14, Y02A 50/30, A61P 29/00, A61K 38/063Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2025-01-31Masahiko MORITApending
PARTICLES USED FOR FORMATION OF PICKERING EMULSION OR LIKEC08F 118/08, C08L 33/12, A61K 8/06, A61K 8/81, A61K 8/8152, C08F 116/06, C08G 81/021, C08L 29/04Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-12-12Takashi YAMAZAKIpending
ANTI-FGF23 ANTIBODY OR ANTIBODY FRAGMENT THEREOFA61K 39/395, C07K 16/22, A61P 7/00, A61P 19/08, A61K2039/505, C07K 16/00, C07K2317/52, C07K2317/524, C07K2317/526, C07K2317/56, C07K2317/565, C07K2317/72, C07K2317/76, C07K2317/92, C07K2317/94, C12N 5/10, C12N 15/63, C12N 15/74, C12N 15/80, C12N 15/81Filed as Kyowa Kirin Co., Ltd.2024-11-29Hikaru MIYAGI12606615
BISPECIFIC ANTIBODY THAT BINDS TO CD116 AND CD131C07K 16/2866, C12N 15/62, A61P 43/00, A61K2039/505, C07K 16/2863, C07K 16/2896, C07K2317/21, C07K2317/24, C07K2317/31, C07K2317/34, C07K2317/51, C07K2317/515, C07K2317/52, C07K2317/53, C07K2317/55, C07K2317/56, C07K2317/71, C07K2317/74, C07K2317/75, C07K2317/92, C12N 5/10, C12N 15/63, C12N 15/70Filed as KYOWA KIRIN CO., LTD.2024-11-29Akifumi KATOpending
PRODUCTION METHOD FOR LACTODIFUCOTETRAOSE (LDFT)C12P 19/00, C12P 19/18, C12R2001/19, C12N 1/20, C12N 9/1051, C12P 19/04, C12Y 204/01069Filed as Kirin Holdings Kabushiki Kaisha2024-09-24Tomotoshi SUGITApending
PROTEIN HAVING ALPHA-1,2-FUCOSYLTRANSFERASE ACTIVITY AND METHOD FOR PRODUCING LACTO-N-FUCOPENTAOSE I (LNFPI)C12N 15/70, C12P 19/04, C12R2001/19, C12N 1/20, C12N 9/1051, C12P 19/18, C12Y 204/01069Filed as Kirin Holdings Kabushiki Kaisha2024-09-24Sayaka KAMAIpending
SpoonFiled as KIRIN HOLDINGS KABUSHIKI KAISHA2024-08-26Hiroaki KANOpending
METHOD FOR PRODUCING OLIGOSACCHARIDE HAVING LEWIS X SKELETONC12N 9/10, C12P 19/18, C07H 5/06, C12N 9/1051, C12N 15/70, C12P 19/04, C12Y 204/01065Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-08-09Tomotoshi SUGITApending
LACTIC ACID BACTERIUM-CONTAINING TABLETSA61P 1/00, A61K 35/744, A23K 10/16, A23L 5/00, A23L 33/125, A23L 33/15, A23L 33/135, A61P 37/04, A61P 3/06, C12R2001/46, A61K 9/0056, A61K 9/2013, A61K 9/2018, A61K 9/2054, A61K 31/7048, A61K2035/115Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-08-02Sayuri TANAKApending
Method for Treating Prurigo NodularisFiled as Kyowa Kirin Co. Ltd.2024-07-18Prista Charuwornpending
COMPOUND WITH ANTICANCER ACTIVITYA61P 35/00, C07D 215/44, C07D 495/14, A61K 31/4709, A61K 31/4985, C07D 209/08, C07D 215/46, C07D 261/08, C07D 401/12, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/12, C07D 413/14, C07D 487/04, C07D 487/08, C07D 519/00Filed as KYOWA KIRIN CO., LTD.2024-06-21Kenji UCHIDApending
FERMENTATION COMPOSITION AND METHOD FOR PRODUCING SAMEA23C 9/12, A23C 9/123, A23V2400/249, A23V2400/21, A23C 9/1234Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-06-12Akiko NAKANOpending
AGENT FOR INHIBITING PROLIFERATION OF SARS-CoV-2A23L 33/135, A61P 31/14, A61K 35/744, A23L 33/10, A23L 2/382, C12C 5/00, C12G 3/02, C12G2200/21Filed as Kirin Holdings Kabushiki Kaisha2024-04-25Hiroshi ISHIIpending
BEVERAGE, AND METHOD FOR PRODUCING SAMEA23C 9/123, A23L 33/135, A23V2400/231, A23C 9/152, A23L 2/38, A23L 2/68Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-04-24Mihoko SUZUKIpending
METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOFC07K 16/22, A61P 9/12, A61K 39/3955, A61K 45/06, A61K2039/505, C07K2317/24, C07K2317/565, C07K2317/76, C07K2317/92Filed as Kyowa Kirin Co., Ltd.2024-03-28Hiroyuki Ariyamapending
SUPPLEMENT COMPOUNDING AND PREPARATION TERMINAL, SUPPLEMENT SUPPLY SYSTEM, AND SUPPLEMENT COMPOUNDING AND PREPARATION METHODG16H 70/40, G16H 20/10, G16H 20/60, G16Y 10/60, G16Y 20/40, G16Y 40/20, G06Q 50/22Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-03-19Hiroyuki HIDApending
AGENT FOR INDUCING INTERFERON PRODUCTION CONTAINING LACTIC ACID BACTERIAA61K 35/744, A23L 33/135, A61P 37/04, A61P 43/00, A61P 31/12, C12R2001/01, C12N 1/205, A23V2400/231, A23C 9/123, A23C 9/1236, A23C 19/0323, A23C 19/062, A61K 9/0053, A61K 31/711, A61K 35/747, C12N 1/20, C12N 15/746, C12Q 1/6809, G01N 33/6866Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-03-08Daisuke FUJIWARA12485150
PHARMACEUTICAL COMPOSITIONA61K 9/0048, A61K 9/14, A61K 31/4709, A61K 47/40, A61K 47/6951, A61P 27/02, A61P 9/10, A61K 9/08, A61K 9/5138, A61K 9/5161, A61K 31/4439, A61K 31/517, A61K 45/00, A61K 47/02, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/32, A61K 47/34, A61K 47/38Filed as Kyowa Kirin Co., Ltd.2024-03-07Hiroki HANIUDApending
BISPECIFIC ANTIBODY THAT BINDS TO CD116 AND CD131C07K 16/2866, C12N 15/62, A61P 43/00, A61K2039/505, C07K 16/2863, C07K 16/2896, C07K2317/21, C07K2317/24, C07K2317/31, C07K2317/34, C07K2317/51, C07K2317/515, C07K2317/52, C07K2317/53, C07K2317/55, C07K2317/56, C07K2317/71, C07K2317/74, C07K2317/75, C07K2317/92, C12N 5/10, C12N 15/63, C12N 15/70Filed as KYOWA KIRIN CO., LTD2024-02-26Akifumi KATO12187803
ANTIBACTERIAL PARTICLES CONTAINING CATIONIC POLYMERA23B 2/729, A01P 1/00, A01N 25/10, A01N 25/12, A01N 33/12Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-02-23Daisuke NAGAOpending
PACKAGED BEVERAGE HAVING SUPPRESSED OFFENSIVE TASTE AND ODOR ASSOCIATED WITH LACTIC ACID BACTERIA, AND METHOD FOR PRODUCING SAMEA23L 2/38, A23L 2/60, A23L 27/84, A23L 33/135, C12R2001/46, A23L 2/56, C12N 1/20Filed as KIRIN BEVERAGE COMPANY, LIMITED2024-01-31Ayumi KITAZAWApending
LACTIC ACID BACTERIUM-CONTAINING BEVERAGE AND METHOD FOR PRODUCING SAMEA23L 2/52, A23L 29/065, A23L 33/135, C12N 1/205, C12R2001/225, C12R2001/46, A23V2400/231, A23L 2/38, A23L 2/39, C12N 1/20Filed as KIRIN HOLDINGS KABUSHIKI KAISHA2024-01-25Yu HIROSEpending

Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.

More on KNBWY

Company overviewEverything on KNBWY in one place, with the price.Who owns itEvery manager reporting a position in KNBWY.LobbyingWhat KNBWY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on KNBWY's account, and who they worked for.

Related datasets

Corporate LobbyingWhat companies spend lobbying Congress, and on what.Lobbying FirmsThe shops companies hire, and who else they represent.Government ContractsWhat federal agencies pay those same companies.Revolving DoorFormer staff now lobbying, and who they worked for.